24:36

Out Of Specification (OOS) Investigation Phase Ia & Phase Ib (MHRA)

20:35

What is significant change in the stability study?

20:30

Top 10 Stability Study Questions On ANDA Filing

13:10

5 Important Interview Questions on Stability Study

19:37

Revised Out of Specification (OOS) Guidance | USFDA Guidance | OOS Guidance May 2022

29:59

Handling Out Of Specification (OOS) results

32:41

Q2(R2): Performance Characteristic

11:04

Out of specification (OOS) and Out of trend (OOT) in pharmaceutical industry l important questions